CARLSBAD, Calif., March 11, 2012 (GLOBE NEWSWIRE) -- Sharewell Capital Group, Inc. (OTC:SHCG) ("Sharewell or the "Company") announced today that C. K. Cooper & Company, an independent, full-service investment bank, headquartered in Irvine, Calif. has resumed coverage on the Healthcare sector with the Initiation of DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA).
Alexander G. Montano, President of C. K. Cooper & Company stated, "With this initiation, we are pleased to bring our unique research insight back into Healthcare. With the addition of Ken Trbovich in January of this year, and the re-initiation of our Healthcare research product, we are excited to bring our unique perspective back into this very dynamic space."
Sharewell has an in-direct minority interest in C. K. Cooper & Company as part of its strategy to develop a portfolio of financial service investments that position us to benefit from niche penetration within the sector.
C. K. Cooper & Company
C. K. Cooper & Company is a full-service investment bank headquartered in Irvine, California. The Company is focused on providing superior and insightful research coverage to its clients; innovative investment banking solutions supported by sales and trading services; and portfolio advisory and management services for private clients. Though C. K. Cooper & Company has been noted for a variety of measures of accomplishment, we chart our success by only one metric: The growth of our clients. For more about C. K. Cooper & Company, visit www.ckcooper.com.
Background on Sharewell Capital Group, Inc.
Sharewell Capital Group, Inc. ("Sharewell") is a publicly-traded holding company focused on acquiring controlling interests and making strategic investments in undervalued assets with significant growth potential. Sharewell is headquartered in San Diego, California, and is publicly-traded under the symbol SHCG. Sharewell was organized in December of 2010, and is embarking on an aggressive business plan to raise permanent capital, conduct extensive diligence and sign letters of intent with initial target acquisitions, in order to build a portfolio of companies and assets with the potential to create significant shareholder equity over time. Our aim is to maximize the growth and profitability of our portfolio companies and strategic investments, and hold or exit as deemed prudent for our shareholders.